Filter Results:
(1,488)
Show Results For
- All HBS Web
(1,488)
- People (1)
- News (333)
- Research (795)
- Multimedia (8)
- Faculty Publications (574)
Show Results For
- All HBS Web
(1,488)
- People (1)
- News (333)
- Research (795)
- Multimedia (8)
- Faculty Publications (574)
- 2018
- Chapter
The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century
By: Nicholas Bagley, Benjamin Berger, Amitabh Chandra, Craig Garthwaite and Ariel Dora Stern
On the 35th anniversary of the adoption of the Orphan Drug Act (ODA), we describe the enormous changes in the markets for therapies for rare diseases that have emerged over recent decades. The most prominent example is the fact that the profit-maximizing price of new... View Details
Keywords: Health Care and Treatment; Laws and Statutes; Research and Development; Investment; Markets; Monopoly
Bagley, Nicholas, Benjamin Berger, Amitabh Chandra, Craig Garthwaite, and Ariel Dora Stern. "The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century." Chap. 4 in Innovation Policy and the Economy, Volume 19, edited by Josh Lerner and Scott Stern, 97–137. University of Chicago Press, 2018.
- 01 Mar 2012
- News
Faculty Research Online
Rethinking the Fairness of Organ Transplants Because of an organ shortage, thousands of people miss out on needed organ transplants each year. Business researchers at Harvard and MIT are rethinking how kidney transplants are allocated to give patients longer lives. An... View Details
- Article
Putting Patients First: Social Marketing Strategies for Treating HIV in Developing Nations
By: Zoe Chance and Rohit Deshpandé
It is more than mere coincidence that the highest rates of HIV occur in the world's poorest countries. Of the over 40 million people currently living with HIV, 95 percent are in the developing world. The first part of this paper explores the economics of HIV and... View Details
Keywords: Health Disorders; Developing Countries and Economies; Poverty; Health Care and Treatment; Social Marketing; Perspective; Customer Focus and Relationships; Profit; Africa; Asia; South America
Chance, Zoe, and Rohit Deshpandé. "Putting Patients First: Social Marketing Strategies for Treating HIV in Developing Nations." Special Issue on Metric and Interpretive Explorations of Macromarketing. Journal of Macromarketing 29, no. 3 (September 2009).
- 28 Feb 2020
- News
Filling the White Space
At Able Partners, Amanda Eilian (MBA 2006) and Lisa Blau (MBA 2003) have focused primarily on women-led wellness companies, including businesses such as Goop, Moon Juice, and Daily Harvest. Now the New York–based investment firm has turned its attention to Compass... View Details
- July 2000 (Revised November 2001)
- Case
Catalyst Medical Solutions
By: Amy C. Edmondson, Richard M.J. Bohmer and Naomi Atkins
Faced with a drop in the NASDAQ, four eHealth entrepreneurs must decide between two distribution strategies for their new company's technology. The team, comprised of three full-time resident physicians and an MBA, has developed software to enable electronic... View Details
Keywords: Product Development; Health Care and Treatment; Distribution; Strategy; Venture Capital; Applications and Software; Partners and Partnerships; Borrowing and Debt; Information Technology Industry; Service Industry
Edmondson, Amy C., Richard M.J. Bohmer, and Naomi Atkins. "Catalyst Medical Solutions." Harvard Business School Case 601-014, July 2000. (Revised November 2001.)
- 16 Jul 2019
- News
The Making of a Movement
repeat riders, we realized Cycle for Survival could have a bigger impact than anyone ever imagined,” says David. Given their marketing and finance experience (Jen was Nickelodeon’s senior vice president of consumer marketing; David was... View Details
- September 2010
- Teaching Note
Acumen Fund: Measurement in Impact Investing (TN) (A) and (B)
By: Alnoor Ebrahim
Teaching Note for 310011 and 310017. View Details
- August 2001
- Case
Scios, Inc.
Scios, filled with distinguished scientists and experienced managers, nevertheless fails to clear the FDA Phase III process for an important biotechnology drug. This case asks the students to analyze the social costs and benefits of the regulatory process. View Details
- 06 Sep 2024
- Blog Post
Harvard Business School Announces 2024 Goldsmith Fellows
effort to create a network of individuals committed to working in social enterprise. The 2024 Goldsmith Fellows are: Princess Aghayere. Princess is co-founder and director of finance for Rebound Liberia, a nonprofit organization dedicated... View Details
- 25 Oct 2024
- Blog Post
Harvard Business School Announces Latest RISE Fellows
training to scale his impact on care delivery at the health systems level. Dion Boyd (MBA 2026)Prior to HBS, Dion created Up Your Equity, a company that aims to combat the racial wealth gap with financial education. There he taught... View Details
- 01 Jun 2011
- News
Howard Stevenson: The Personal Side
himself not just to HBS but to the community. As a trustee of Mount Auburn Hospital in Cambridge, he has been invaluable in helping them to proactively address the complex financing decisions that the last several years in View Details
- April 2017
- Supplement
Imprimis (C)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A & B). Set in 2015, it first describes Imprimis’s decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the... View Details
Keywords: Health Care and Treatment; Cost; Moral Sensibility; Competitive Strategy; Decision Choices and Conditions; Pharmaceutical Industry; United States
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (C)." Harvard Business School Supplement 717-497, April 2017.
- 11 Dec 2018
- First Look
New Research and Ideas, December 11, 2018
2018 Oxford University Press Food Citizenship: Food System Advocates in an Era of Distrust By: Goldberg, Ray A. Abstract—The global food system is the largest segment of the world's economy. As agribusiness-studies pioneer Ray Goldberg suggests, it is also the largest... View Details
Keywords: Dina Gerdeman
- February 2021
- Supplement
HNA Group: Global Excellence with Chinese Characteristics (C)
By: William C. Kirby, Billy Chan and John P. McHugh
July 2017 was supposed to be a triumphant month for HNA Group. The latest Fortune Global 500 list showed the company had again skyrocketed in its ranking to no. 170, an improvement of over 200 positions from the year prior. Yet earlier that same July, the mysterious... View Details
Keywords: Conglomerate; Airline Industry; Coronavirus; Financial Risk; Debt; Bankruptcy; Global Strategy; Restructuring; Health Pandemics; Financial Markets; Organizational Change and Adaptation; Financial Condition; Globalized Firms and Management; Business and Government Relations; Air Transportation Industry; Financial Services Industry; China
Kirby, William C., Billy Chan, and John P. McHugh. "HNA Group: Global Excellence with Chinese Characteristics (C)." Harvard Business School Supplement 321-123, February 2021.
- 01 Jun 2024
- News
Turning Point: On the Line
Theatricals. One of the great 14-year-old Tevyes in a summer-camp production of Fiddler on the Roof. Disney was my foot in the door. While churning out budgets and quarterly projections as a finance executive, I took a sitcom-writing... View Details
- 01 Jun 2006
- News
The Baby Business
for creating and acquiring children is, Spar argues, disorganized, legally conflicted, and virtually unfettered. It includes people who sell their eggs; buy sperm from strangers; undergo fertilization procedures; pay surrogates to bear children; and View Details
- August 2012 (Revised August 2024)
- Case
ABC Pharmaceuticals
By: Regina E. Herzlinger and Erik R. Sparks
This case asks students to price a new drug that is in Stage II of its clinical trials. It contains detailed estimates of the time required and costs for all the steps needed to commercialize a drug in the U.S. Students will learn virtually all the steps required to... View Details
Keywords: Drug Development; Price; Product; Product Launch; Health Industry; Health Industry; Health Industry
Herzlinger, Regina E., and Erik R. Sparks. "ABC Pharmaceuticals." Harvard Business School Case 313-041, August 2012. (Revised August 2024.)
- Article
Invisible Monuments and the Costs of Pharmaceutical Regulation: Twenty-Five Years of Drug Lag Debate
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "Invisible Monuments and the Costs of Pharmaceutical Regulation: Twenty-Five Years of Drug Lag Debate." Pharmacy in History 45, no. 1 (2003): 3–17.
- 24 Oct 2006
- First Look
First Look: October 24, 2006
and AIDS: The Macroeconomic Impact of a Health Crisis Authors:Eric D. Werker, Amrita Ahuja, and Brian Wendell Abstract Theories abound on the potential macroeconomic impact of AIDS in Africa, yet there have been surprisingly few empirical... View Details
Keywords: Sean Silverthorne